REQUEST A DEMO
Total
USD $0.00
Search more companies

Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Pharmaceutical Preparation Manufacturing | Office Machinery and Equipment Rental and Leasing | Research and Development in the Physical, Engineering, and Life Sciences | Office Administrative Services | Educational Services | Ambulatory Health Care Services
Full name: Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. Profile Updated: October 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. is based in Poland. The head office is in Nowy Sacz. It operates in the General Medical and Surgical Hospitals sector. The company was established on January 31, 2019. From the latest financial highlights, Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. reported a net sales revenue increase of 14.86% in 2024. Its’ total assets recorded a growth of 33.44%. In 2024, Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k.’s net profit margin increased by 6.82%.

Headquarters
Ul. Zywiecka 44
Nowy Sacz; Malopolskie; Postal Code: 33-300

Contact Details: Purchase the Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
January 31, 2019
Company Performance
Financial values in the chart are available after Centrum Medyczne Zywiecka 44 Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.86%
Total operating revenue
14.76%
Operating profit (EBIT)
379.3%
EBITDA
271.12%
Net Profit (Loss) for the Period
369.9%
Total Assets
33.44%
Total Equity
73.95%
Operating Profit Margin (ROS)
7.63%
Net Profit Margin
6.82%
Return on Equity (ROE)
26.77%
Quick Ratio
1.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?